1. Bacal DA. Amblyopia treatment studies. Curr Opin Ophthalmol. 2004. 15:432–436.
2. von Noorden GK, Campos E. Binocular vision and ocular motility: theory and management of strabismus. 2002. 6th ed. St. Louis: Mosby;537–558.
3. Pandey PK, Chaudhuri Z, Kumar M, et al. Effect of levodopa and carbidopa in human amblyopia. J Pediatr Ophthalmol Strabismus. 2002. 39:81–89.
4. Kaye SB, Chen SI, Price G, et al. Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia. J AAPOS. 2002. 6:289–293.
5. Roberts CJ, Adams GGW. Contact lenses in the management of high anisometropic amblyopia. Eye. 2002. 16:577–579.
6. Autrata R, Rehurek J. Laser-assisted subepithelial keratectomy and photorefractive keratectomy versus conventional treatment of myopic anisometropic amblyopia in children. J Cataract Refract Surg. 2004. 30:74–84.
7. Hiscox F, Strong N, Thompson JR, et al. Occlusion for amblyopia: a comprehensive survey of outcome. Eye. 1992. 6:300–304.
8. Olson RJ, Scott WE. A practical approach to occlusion therapy for amblyopia. Semin Ophthalmol. 1997. 12:161–165.
9. Rutstein RP. Alternative treatment for amblyopia. Probl Optom. 1991. 3:351–354.
10. Repka MX, Beck RW, Holmes JM, et al. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003. 121:603–611.
11. Holmes JM, Kraker RT, Beck RW, et al. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003. 110:2075–2087.
12. Scott WE, Kutschke PJ, Keech RV, et al. Amblyopia treatment outcomes. J AAPOS. 2005. 9:107–111.
13. Awan M, Proudlock FA, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci. 2005. 46:1435–1439.
14. Stewart CE, Fielder AR, Stephens DA, Moseley MJ. Treatment of unilateral amblyopia: factors influencing visual outcome. Invest Ophthalmol Vis Sci. 2005. 46:3152–3160.
15. Malik SRK, Virdi PS, Goel BK. Follow-up results of occlusion and pleoptic treatment. Acta Ophthalmol. 1975. 53:620–625.
16. Sparrow JC, Flynn JT. Amblyopia: a long-term follow-up. J Pediatr Ophthalmol. 1977. 14:333–336.
17. Bowman RJC, Williamson TH, Andrews RGL, et al. An inner city preschool visual screening programme: long term visual results. Br J Ophthalmol. 1998. 82:543–548.
18. Levartovsky S, Gottesman N, Shimshoni M, Oliver M. Factors affecting long-term results of successfully treated amblyopia: age at beginning of treatment and age at cessation of monitoring. J Pediatr Ophthalmol Strabismus. 1992. 29:219–223.
19. Leiba H, Shimshoni M, Oliver M, et al. Long-term follow-up of occlusion therapy in amblyopia. Ophthalmology. 2001. 108:1552–1555.
20. Flynn JT, Schiffman J, Feuer W, Corona A. The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Am Ophthalmol Soc. 1998. 96:431–450. discussion 450-3.
21. Cleary M. Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified? Br J Ophthalmol. 2000. 84:572–578.
22. Mintz Hittner HA, Fernandez KM. Successful amblyopia therapy initiated after age 7 years: compliance cures. Arch Ophthalmol. 2000. 118:1535–1541.
23. Park KH, Hwang JM, Ahn JK. Efficacy of amblyopia therapy initiated after 9 years of age. Eye. 2004. 18:571–574.
24. Scheiman MM, Hertle RW, Beck RW, et al. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005. 123:437–447.
25. Holmes JM, Edwards AR, Beck RW, et al. A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS. 2005. 9:129–136.